Rodríguez AM, Ponce SH

Language: Spanish
References: 11
Page: 16-20
PDF size: 189.98 Kb.

Text Extraction

No abstract

REFERENCES

1. Gilliland B. Esclerodermia, Principios de Medicina Interna de Harrison, 13ma Edición, II: 1904-12.Interamericana, McGraw-Hill, Madrid, España.

2. Robbins S, Cotran R. Esclerodermia, Patología Estructural y Funcional, 3ra Edición, 4: 186-9, Nueva Editorial Interamericana s.a. de c.v., México DF., México.

3. Furst D, Clements P. Hypothesis for the pathogenesis of Systemic Sclerosis. J Rheumatol 1997; 24;Supl.48:53-7.

4. Salojin K, Tonqueze M, Saraux A et al. Antiendothelial Cell AntiboUseful markers of Systemic Sclerosis. Am J Med 1997; 102(2):178-84.

5. Nitta Y, Sobue G. Progressive Systemic Sclerosis Associated with multiple Mononeuropathy. Dermatology 1996; 193:22-26.

6. Silman A, Scleroderma-Demographics and Survival. J Rheumatol 1997; 24;48:58-61.

7. Brooks P. Hematopoietic Stem Cell Transplantation for Autoimmune Diseases. J Rheumatol 1997; 24;48:19-22.

8. Clements P, Furst D. Choosing Appropriate patients with systemic Sclerosis for treatment by Autologuous Stem Cell Transplantation. J Rheumatol 1997; 24; 48:85-8.

9. Nash R, McSweeney P, Storb R et al. Development of a Protocol for Allogeneic Marrow Transplantation for Severe Systemic Sclerosis: Paradigm for Autoimmune Disease. J Rheumatol 1997; 24;48:72-78.

10. Schwartz J, Gonzalez J, Palangio M et al. Extracorporeal photochemotherapy in progressive systemic sclerosis: a follow-up study. Int J Dermatol 1997; 36:380-85.

11. Blaszczyk M, Janniger C, Jablonska S. Childhood scleroderma and its peculiarities. Cutis 1996; 58(2):141-52.